Holen Sie sich die Stockscreener-App
0.4349
0.25%
-0.0011
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
Oragenics (OGEN) Edges Higher as Sub-$1 Biotech Holds Near $0.50Iron Condor Alert - https://www.siam.in/
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum - GlobeNewswire
Oragenics Faces NYSE Compliance Challenges Amid Trial Progress - The Globe and Mail
Oragenics Faces Potential NYSE American Delisting on Equity Shortfall - minichart.com.sg
Oragenics Faces NYSE Compliance Challenges Amid Trial Progress - TipRanks
Oragenics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Oragenics (NYSE: OGEN) faces NYSE listing warning as equity falls short - Stock Titan
Oragenics Updates Phase IIa Trial Progress, FDA Regulatory Pathway and NYSE American Listing Status - Quiver Quantitative
Oragenics Updates Phase IIa Trial Progress, FDA Regulatory Pathway and NYSE American Listing Status - Quiver Quantitative
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update - GlobeNewswire
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update - Yahoo Finance
Oragenics (OGEN) Earnings Report: EPS Exceeds Its Estimate for the Current Session; Trading Response - dars.gov.et
Oragenics (OGEN) Earnings Report: EPS Exceeds Its Estimate for the Current Session; Trading Response - careplusvn.com
Oragenics (OGEN) Earnings Report: EPS Exceeds Its Estimate for the Current Session; Trading Response - www.dars.gov.et
Oragenics (OGEN) Earnings Report: EPS Exceeds Its Estimate for the Current Session; Trading Response - dars.gov.et
Oragenics (OGEN) Slips to $0.53, Holding Key Support Despite 1.16% DeclineRange Breakout - vinanet.vn
Oragenics: Q2 Earnings Snapshot - AOL.com
Oragenics: Q2 Earnings Snapshot - 10TV
Oragenics (OGEN) flags going concern risk with $4.7M loss and $3.9M cash - Stock Titan
Oragenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Oragenics (OGEN) Slips to $0.53, Holding Key Support Despite 1.16% DeclineRange Breakout - vinanet.vn
Oragenics (OGEN) Slips to $0.53, Holding Key Support Despite 1.16% DeclineAAII Bullish - www.dars.gov.et
Oragenics (OGEN) Gains 2% as Micro-Cap Biotech Holds Key Support at $0.47Technical Analysis - vinanet.vn
Oragenics (OGEN) Gains 2% as Micro-Cap Biotech Holds Key Support at $0.47Collar Trade - dars.gov.et
OGEN Q2 2023 Earnings: Narrower EPS Beat Lifts Shares 2.0%Earnings Beat Streak - careplusvn.com
OGEN Q2 2023 Earnings: Narrower EPS Beat Lifts Shares 2.0%Interim Report - vinanet.vn
Oragenics Q2 2023 Earnings: Narrowed Loss Surprises as Operational Efficiency ImprovesEarnings Acceleration Picks - careplusvn.com
Oragenics Q2 2023 Earnings: Narrowed Loss Surprises as Operational Efficiency ImprovesEBITDA Analysis - vinanet.vn
Oragenics Q2 2023 Earnings: Narrowed Loss Surprises as Operational Efficiency ImprovesPre-Earnings Setup - dars.gov.et
Oragenics Inc. Revenue Breakdown – AMEX:OGEN - TradingView
Oragenics Inc (OGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oragenics Inc (OGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oragenics Inc (OGEN) Cash Flow - TradingKey
OGEN|Oragenics Inc|Price:0.507|Chg%:-0.004 - TradingKey
TradingKey - TradingKey
Oragenics Inc (OGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
OGEN Q2 2023 Earnings: EPS Surprises to the Upside Despite No RevenueRevenue Guidance Update - vinanet.vn
OGEN Q2 2023 Earnings: EPS Surprises to the Upside Despite No RevenueOperating Income Trends - dars.gov.et
OGEN Q2 2023 Earnings: EPS Beat on 50.65% Surprise but No Revenue; Stock DeclinesPost-Earnings Drift - vinanet.vn
OGEN Q2 2023 Earnings: EPS Beat on 50.65% Surprise but No Revenue; Stock DeclinesNew Analyst Coverage - dars.gov.et
OGEN Q2 2023 Earnings: EPS Beat on 50.65% Surprise but No Revenue; Stock DeclinesFull Year Guidance - dars.gov.et
OGEN Q2 2023 Earnings: EPS Beats Estimates by 50.65% Despite No Revenue, Stock DeclinesCost Structure Review - vinanet.vn
OGEN Q2 2023 Earnings: EPS Beats Estimates by 50.65% Despite No Revenue, Stock DeclinesEPS Revision Trend - dars.gov.et
OGEN Q2 2023 Earnings: EPS Beats Estimates by 50.65% Despite No Revenue, Stock DeclinesOperating Income Trends - dars.gov.et
Oragenics Inc. (OGEN) Holds Near Support Amid Modest DeclineBPI Bear Correction - dars.gov.et
Oragenics Inc. (OGEN) Holds Near Support Amid Modest DeclineVOLD Alert - careplusvn.com
Oragenics Inc. (OGEN) Holds Near Support Amid Modest DeclineTechnical Analysis - vinanet.vn
OGEN Q2 2023 Earnings: EPS Surprise Beats Estimates Despite Stock DeclineGuidance vs Actual - vinanet.vn
OGEN Q2 2023 Earnings: EPS Surprise Beats Estimates Despite Stock DeclineEarnings Revision Downgrade - www.dars.gov.et
Oragenics Incto Receive Exclusive License - Moomoo
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):